We are live on ! Find out more
CYTH

Cyclo Therapeutics, Inc. Common Stock
CYTH

Delisted

CYTH was delisted on the 25th of March, 2025.

Back to rankings

23 hedge funds and large institutions have $2.1M invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more capital invested

Capital invested by funds: $683K → $2.1M (+$1.42M)

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

35% more funds holding

Funds holding: 17 → 23 (+6)

Holders
23
Holders Change
+6
Holders Change %
+35.29%
% of All Funds
0.34%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
8
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FFVM
Founders Fund V Management
California
+$613K
2
FFVM
Founders Fund VI Management
California
+$140K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$93.3K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$65.7K
5
BlackRock
BlackRock
New York
+$61.3K

Top Sellers

1
VF
Virtu Financial
New York
-$15K
2
XT
XTX Topco
Cayman Islands
-$2.81K
3
TRCT
Tower Research Capital (TRC)
New York
-$1.14K
4
JP Morgan Chase
JP Morgan Chase
New York
-$283
5
UBS Group
UBS Group
Switzerland
-$125
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
26
Simplex Trading
Illinois
– +$255 +200 New
1
2